Dr. Mei Dong 董梅
Chief Physician
Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences (National Cancer Center), Beijing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Treatment of malignant lymphoma, lung cancer, head and neck tumors, breast cancer, gastrointestinal tumors, and other common medical oncology cancers.
Dr. Dong holds a medical doctorate from Peking Union Medical College (2002) and graduated from Xi'an Medical University (1993). A Chief Physician and master's supervisor, Dr. Dong specializes in medical oncology, with extensive experience in treating malignant lymphoma and head and neck tumors. Research interests include clinical and molecular pharmacology of anti-tumor drugs. Dr. Dong has published over 10 papers and co-authored several textbooks.
Name order: in Chinese the family name comes first (Dong Mei). Papers usually list the name as Mei Dong or Dong M.
Selected publications
42 papers on PubMed matched by name and affiliation; 13 as first or senior author since 2016. Most recent first- or senior-author papers:
- Chemotherapy, 2024 (senior author): Treatment and Prognosis of Newly Diagnosed Advanced-Stage Extranodal Natural Killer/T-Cell Lymphoma: A Single-Center Real-World Study across Two Decades. PubMed 37984344
- Ann Hematol, 2024 (senior author): Clinical features, prognostic stratification, and treatment of advanced-stage non-nasal type extranodal natural killer/T-cell lymphoma: a multi-institutional real-world study. PubMed 37817010
- Int J Cancer, 2023 (senior author): Intensive therapy can improve long-term survival in newly diagnosed, advanced-stage extranodal NK/T-cell lymphoma: A multi-institutional, real-world study. PubMed 37539660
- Head Neck, 2023 (senior author): Comparing the role of different treatment modalities in locoregionally advanced olfactory neuroblastoma: The 20-year clinical experience of a single institution. PubMed 37306376
- Otolaryngol Head Neck Surg, 2023 (senior author): Prognostic Assessment and Risk Stratification in Patients With Postoperative Major Salivary Acinar Cell Carcinoma. PubMed 36939406
- Head Neck, 2022 (senior author): Survival and prognosis of metastatic head and neck adenoid cystic carcinoma. PubMed 35822446
- Int J Radiat Oncol Biol Phys, 2022 (senior author): First-Line Chemoradiation With or Without Chidamide (Tucidinostat) in Patients With Intermediate- and High-Risk Early-Stage Extranodal Nasal-Type Natural Killer/T-Cell Lymphoma: A Randomized Phase 2 Study in China. PubMed 35452752
- Blood Adv, 2021 (senior author): Liquid biopsy in extranodal NK/T-cell lymphoma: a prospective analysis of cell-free DNA genotyping and monitoring. PubMed 34047776
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that most papers list this doctor's hospital and department.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion